Asia-Pacific Randomization and Trial Supply Management (RTSM) Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Jul 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 211
  • No of Figures: 52

Asia-Pacific Randomization and Trial Supply Management (RTSM) Market, By Component (Software, Services), Delivery Mode (Licensed Enterprise (On-Premise), Cloud-Based (SaaS), Web Based (On-Demand), Application (Scenario Planning & Forecasting, Aggregation/ Lot Planning, Study Build, Randomization, Drug Dispensing, Reforecast & Optimize, Destruction & Reconciliation, Database Lock, Inventory Management, Others), Clinical Trial Type (Treatment Trials, Prevention Trials, Screening Trials, Supportive Care Trials), Clinical Trial Phase (Early Phase, Phase I clinical trials, Phase II clinical trials, Phase III clinical trials, Phase IV clinical trials and Peri-/Post- Approval), Therapeutic Area (Oncology, Cardiovascular Disease & Circulatory Diseases, Infectious Diseases, Digestive Diseases, Musculoskeletal Diseases, Nervous System Diseases, Endocrinology & Metabolic Diseases, Mental Health & Behavioural Disorders, Blood Diseases, Respiratory Diseases, Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Hospitals, Academic Research Institutes, Government Bodies, Others), Distribution Channel ( Direct Sales, Third Party Distributor), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific) Industry Trends and Forecast to 2028.

Asia-Pacific Randomization and Trial Supply Management (RTSM) Market Market Analysis and Insights: Asia-Pacific Randomization and Trial Supply Management (RTSM) Market

Asia-Pacific randomization and trial supply management (RTSM) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 14.2% in the forecast period of 2021 to 2028 and is expected to reach USD 787.80 million by 2028 from USD 275.22 million in 2020. Increasing incidence of chronic diseases and rising government’s funds for research & development are the major drivers which propelled the demand of the market in the forecast period.

Randomization and trial supply management (RTSM) is a management system that enables critical functions of clinical trial like randomizing patients to determine who gets drugs and placebo treatments, drug dispension capacity to ensure the correct dose of drugs to trial patients, and controls the flow of drug from the pharma or biotechnology companies to the clinical site. RTSM is responsible for patient tracking, medication dispension, cohort management, site activation, and maintaining the entire clinical study in blind nature without revealing data. The main purpose of RTSM is to prevent occurrence of any bias in deciding which patients are assigned for which treatment group during every phase of clinical trial, and to ensure, track, manage and distribute the products to patients from manufacturers safely. For clinical trial regulatory purposes randomization, and trial supply management helps in site activation by notifying distributer with item details.

Randomization and trial supply management (RTSM) demand has increased as compared to the precise year with growing prevalence of chronic diseases and development of personalised medicines. In addition demand of randomization and trial supply management (RTSM) has increased in the developing countries with the increased funding by government for clinical trials. Further adverse side effects and high cost associated with trials is expected to restraint the usage of randomization and trial supply management (RTSM) and is expected to slow down the growth of the market in the forecasted period.  

The Asia-Pacific randomization and trial supply management (RTSM) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Asia-Pacific Randomization and Trial Supply Management (RTSM) Market Asia-Pacific Randomization and Trial Supply Management (RTSM) Market Scope and Market Size

 Asia-Pacific randomization and trial supply management (RTSM) market is categorized into eight notable segments which are based on component, delivery mode, application, clinical trial type, clinical trial phase, therapeutic area, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of component, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into software and services. In 2021, software segment is expected to dominate the randomization and trial supply management market due to COVID-19 pandemic and corresponding lockdown declarations and rising online-based trial practices with advanced RTSM software.
  • On the basis of delivery mode, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into licenced enterprise (on-premise), cloud- based (SaaS), and web-based (on-demand). In 2021, licenced enterprise (on-premise) segment is expected to dominate the randomization and trial supply management market due to surge in technological advancements in novel and high storage capacity for trial data of patients.
  • On the basis of application, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into scenario planning & forecasting, aggregation/ lot planning, study build, randomization, drug dispensing, reforecast & optimize, destruction & reconciliation, database lock, inventory management and others. In 2021, randomization segment is expected to dominate the randomization and trial supply management market due to an increase in the demand for randomization of sample trials.
  • On the basis of clinical trial type, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into treatment trails, prevention trials, screening trials, supportive care trails. In 2021, treatment trials segment is expected to dominate the Asia-Pacific randomization and trial supply management (RTSM) market as there is a high requirement of therapeutic options needed for various chronic diseases such as cancer, cardiac diseases and among others.
  • On the basis of clinical trial phase, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into early phase, phase I clinical trials, phase II clinical trials, phase III clinical trials, phase IV clinical trials and peri-/post- approval. In 2021, phase III clinical trials segment is expected to dominate the Asia-Pacific randomization and trial supply management (RTSM) market as it will lead to the approvals from the specific countries' government regulatory authorities.  
  • On the basis of therapeutic area, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into oncology, cardiovascular disease & circulatory diseases, infectious diseases, digestive diseases, musculoskeletal diseases, nervous system diseases, endocrinology & metabolic diseases, mental health & behavioural disorders, blood diseases, respiratory diseases and others. In 2021, oncology segment is expected to dominate the Asia-Pacific randomization and trial supply management (RTSM) market because of the increase in number of patients with cancer and research on cancer in clinical trials is also rising significantly.
  • On the basis of end user, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device manufacturers, hospitals, academic research institutes, government bodies and others. In 2021, pharmaceutical and biopharmaceutical companies segment is expected to dominate the Asia-Pacific randomization and trial supply management (RTSM) market due to rise in research and development activities initiated by new pharmaceutical and biopharma companies.
  • On the basis of distribution channel, the Asia-Pacific randomization and trial supply management (RTSM) market is segmented into direct sales and third party distributor. In 2021, direct sales segment is expected to dominate the Asia-Pacific randomization and trial supply management (RTSM) market as it provides quality and accessible clinical trial managing services to various pharmaceutical companies, biotechnology companies and contract research organizations

Asia-Pacific Randomization and Trial Supply Management (RTSM) Market Country Level Analysis

Asia-Pacific randomization and trial supply management (RTSM) market is categorized into eight notable segments which are based on component, delivery mode, application, clinical trial type, clinical trial phase, therapeutic area, end users and distribution channel.

The countries covered in the Asia-Pacific randomization and trial supply management market report are the Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.   

China is leading the growth of the Asia-Pacific market due to increasing focus on the clinical trials and high number of patient volunteers.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

New Drug Development and Availability in Emerging Countries and Increasing Demand for Innovative Clinical Trial Solutions in Asia-Pacific Randomization and Trial Supply Management (RTSM) Market is Creating New Opportunities for Players

 Asia-Pacific randomization and trial supply management (RTSM) market also provides you with detailed market analysis for every country growth in particular industry with dermatology drug sales, impact of advancement in the Asia-Pacific randomization and trial supply management (RTSM) market and changes in regulatory scenarios with their support for the Asia-Pacific randomization and trial supply management (RTSM) market. The data is available for historic period 2010 to 2019. 

Competitive Landscape and Asia-Pacific Randomization and Trial Supply Management (RTSM) Market Share Analysis

Asia-Pacific randomization and trial supply management (RTSM) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific randomization and trial supply management (RTSM) market.

The major players covered in the report are are Cenduit LLC, ICON plc, Parexel International Corporation, IBM Corporation, 4G Clinical, Ennov, Bioclinica., eClinical Solutions LLC., Statistics & Data Corporation, Baiao known,  Zhejiang Taimei Medical Technology Co., Ltd., Medrio, Inc., IDDI., Oracle, Medidata Solutions, Inc. (Dassault Systemes) and among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Asia-Pacific randomization and trial supply management (RTSM) market

For instance,

  • In April 2019, IBM Corporation   Launches Advanced Storage Solutions Designed to Simplify Data Accessibility & Availability Across Hybrid Clouds. This new solution launch by parent organization IBM has enhanced the company’s overall revenue for market
  • In February 2021, ICON plc announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. The motive of this strategic acquisition was to improve their clinical trial management from both companies to enhance value to patients, customers, employees and share-holders

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the Asia-Pacific randomization and trial supply management (RTSM) market which also provides the benefit for organisation to improve their offering for clinical trials.

Customization Available: Asia-Pacific Randomization and Trial Supply Management (RTSM) Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 2 ASIA-PACIFIC SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC AGGREGATION/ LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 21 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 22 CHINA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 23 CHINA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 24 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 25 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 CHINA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 27 CHINA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 28 CHINA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 CHINA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 30 CHINA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 CHINA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 32 CHINA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 CHINA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 CHINA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 36 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 37 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 38 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 39 CHINA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 41 JAPAN SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 42 JAPAN SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 43 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 44 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 JAPAN RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 JAPAN AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 JAPAN DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 48 JAPAN INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 JAPAN SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 JAPAN STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 JAPAN DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 52 JAPAN REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 JAPAN DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 55 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 56 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 57 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 JAPAN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 60 INDIA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 61 INDIA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 62 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 63 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 64 INDIA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 INDIA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 INDIA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 INDIA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 68 INDIA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 69 INDIA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 70 INDIA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 71 INDIA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 72 INDIA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 74 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 75 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 76 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 77 INDIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 78 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 79 SOUTH KOREA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 80 SOUTH KOREA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 81 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 82 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 83 SOUTH KOREA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 84 SOUTH KOREA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 85 SOUTH KOREA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 SOUTH KOREA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 SOUTH KOREA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 88 SOUTH KOREA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 89 SOUTH KOREA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 90 SOUTH KOREA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 91 SOUTH KOREA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 92 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 93 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 94 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 95 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 96 SOUTH KOREA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 97 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 98 AUSTRALIA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 99 AUSTRALIA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 100 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 101 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 102 AUSTRALIA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 103 AUSTRALIA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 104 AUSTRALIA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 AUSTRALIA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 106 AUSTRALIA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 AUSTRALIA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 AUSTRALIA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 109 AUSTRALIA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 AUSTRALIA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 111 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 112 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 113 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 114 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 115 AUSTRALIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 116 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 117 SINGAPORE SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 118 SINGAPORE SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 119 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 120 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 121 SINGAPORE RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 122 SINGAPORE AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 123 SINGAPORE DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 124 SINGAPORE INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 125 SINGAPORE SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 126 SINGAPORE STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 SINGAPORE DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 128 SINGAPORE REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 129 SINGAPORE DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 130 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 131 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 132 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 133 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 134 SINGAPORE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 135 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 136 MALAYSIA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 137 MALAYSIA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 138 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 139 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 140 MALAYSIA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 141 MALAYSIA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 142 MALAYSIA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 143 MALAYSIA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 144 MALAYSIA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 145 MALAYSIA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 MALAYSIA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 MALAYSIA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 148 MALAYSIA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 149 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 150 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 151 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 152 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 153 MALAYSIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 154 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 155 THAILAND SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 156 THAILAND SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 157 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 158 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 159 THAILAND RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 160 THAILAND AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 161 THAILAND DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 162 THAILAND INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 163 THAILAND SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 164 THAILAND STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 165 THAILAND DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 166 THAILAND REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 167 THAILAND DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 168 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 169 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 170 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 171 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 172 THAILAND RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 173 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 174 INDONESIA SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 175 INDONESIA SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 176 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 177 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 178 INDONESIA RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 179 INDONESIA AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 180 INDONESIA DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 INDONESIA INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 182 INDONESIA SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 183 INDONESIA STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 184 INDONESIA DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 185 INDONESIA REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 186 INDONESIA DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 187 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 188 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 189 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 190 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 191 INDONESIA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 192 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 193 PHILIPPINES SOFTWARE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 194 PHILIPPINES SERVICES IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 195 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 196 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 197 PHILIPPINES RANDOMIZATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 198 PHILIPPINES AGGREGATION/LOT PLANNING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 199 PHILIPPINES DRUG DISPENSING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 200 PHILIPPINES INVENTORY MANAGEMENT IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 201 PHILIPPINES SCENARIO PLANNING & FORECASTING IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 202 PHILIPPINES STUDY BUILD IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 203 PHILIPPINES DATABASE LOCK IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 204 PHILIPPINES REFORECAST & OPTIMIZE IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 205 PHILIPPINES DESTRUCTION & RECONCILIATION IN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 206 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL TYPE, 2019-2028 (USD MILLION)

TABLE 207 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY CLINICAL TRIAL PHASE, 2019-2028 (USD MILLION)

TABLE 208 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY THERAPEUTIC AREA, 2019-2028 (USD MILLION)

TABLE 209 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 210 PHILIPPINES RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 211 REST OF ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions